MedChem Products Inc. said@#%^&*1
a U.S. District Court in Boston ruled@#%^&*1
that a challenge by MedChem to the validity of a U.S. patent@#%^&*1
held by Pharmacia Inc.@#%^&*1
was "without merit."@#%^&*2
Pharmacia,@#%^&*3
based in Upsala, Sweden,@#%^&*3
had charged in a lawsuit against MedChem@#%^&*3
that MedChem's AMVISC product line infringes on the Pharmacia patent.@#%^&*3
The patent is related to hyaluronic acid, a rooster-comb extract@#%^&*4
used in eye surgery.@#%^&*4
In its lawsuit, Pharmacia is seeking unspecified damages and a preliminary injunction@#%^&*5
to block MedChem from selling the AMVISC products.@#%^&*5
A MedChem spokesman said@#%^&*6
the products contribute about a third of MedChem's sales and 10% to 20% of its earnings.@#%^&*6
In the year@#%^&*7
ended Aug. 31, 1988,@#%^&*7
MedChem earned $2.9 million, or 72 cents a share, on sales of $17.4 million.@#%^&*7
MedChem said@#%^&*8
the court's ruling was issued as part of a "first-phase trial" in the patent-infringement proceedings@#%^&*8
and concerns only one of its defenses in the case.@#%^&*8
It said@#%^&*9
it is considering "all of its options in light of the decision,@#%^&*9
including a possible appeal."@#%^&*9
The medical-products company added@#%^&*10
that it plans to "assert its other defenses" against Pharmacia's lawsuit,@#%^&*10
including the claim@#%^&*10
that it hasn't infringed on Pharmacia's patent.@#%^&*10
MedChem said@#%^&*11
that the court scheduled a conference for next Monday@#%^&*11
-- to set a date for proceedings on Pharmacia's motion for a preliminary injunction.@#%^&*11
